Press Releases - 2023-05-18

Date	Title	Company
18-May-2023	U.S. IVF Services Market Is Set to Register CAGR of 6.8% by 2027 \| Report by AMR	The Wire Times
18-May-2023	Chronic Hemodialysis Catheter Market: Meeting the Demand for Renal Care \| Nipro Medical, Teleflex, BD, Fresenius	The Wire Times
18-May-2023	Genome Editing Market: Shaping the Future of Genetic Engineering \| Agilent Technologies, CRISPR Therapeutics, Danaher, GenScript, Lonza	The Wire Times
18-May-2023	Biomaterials Market Update 2023: Revenue to Cross USD 2,12,405.2 Million by 2030, Exclusive Report	The Wire Times
18-May-2023	Smart Inhalers Market Size Revenue To Cross USD 1.1 billion by 2030 \| CAGR of 25.1%	The Wire Times
18-May-2023	CliniOps Awarded Patent for Pioneering System to Collect Location Agnostic Clinical and Non-Clinical Data	Newswire
18-May-2023	Celerion Receives a 2023 CRO Leadership Award in All Categories for the Eighth Year Running	Celerion
18-May-2023	Global Mental Health Market to Grow at a CAGR of 3.5% from 2021 to 2030, Driven by Rising Awareness and Technological Advancements	The Wire Times
18-May-2023	Bloomsbury Genetic Therapies Outlines Pre-Clinical Data on CNS Programs Presented at the American Society of Gene and Cell Therapy 26th Annual Meeting	Bloomsbury Genetic Therapies
18-May-2023	Orgenesis announces collaboration agreement with SCTbio to expand POCare sites in the Czech Republic and enhance capabilities for the production of lentivirus vectors	Orgenesis
18-May-2023	A key barometer of global drug delivery and packing innovation: the Pharmapack Awards 2024 open for entries	CPHI
18-May-2023	Convatec Group Plc (Convatec) AGM trading update for the four months ended 30 April 2023	Convatec Group Plc
18-May-2023	Kynos Therapeutics announces a first-in-human Phase I study of its novel small molecule KMO inhibitor, KNS366, is underway	Kynos Therapeutics
18-May-2023	PHTA and Oxford Science Enterprises join forces to accelerate innovation	Precision Health Technologies Accelerator (PHTA)
18-May-2023	FORXIGA (DAPAGLIFLOZIN) IS THE FIRST AND ONLY TREATMENT RECOMMENDED BY NICE FOR CHRONIC HEART FAILURE WITH AN EJECTION FRACTION >40%, POTENTIALLY IMPACTING UP TO HALF A MILLION PATIENTS IN ENGLAND AND WALES	AstraZeneca
18-May-2023	Bloom Science Names Top Biotechnology Executive, Dr. Grace E. Colón, Board Chair	Bloom Science
18-May-2023	Immutep's efti combination with pembrolizumab achieves excellent initial overall survival benefit in first-line non-small cell lung cancer	Immutep Limited
18-May-2023	GILEAD AND KITE ONCOLOGY TO SHOWCASE ADVANCES ACROSS THE PIPELINE AIMING TO ADDRESS UNMET NEEDS IN CANCER CARE AT ASCO 2023	Gilead Sciences, Inc.
18-May-2023	Torx® , the collaborative chemistry platform, announce enhanced CRO capabilities in Spring release	Torx Software Limited
18-May-2023	Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)